Skip to main content
Premium Trial:

Request an Annual Quote

Intermountain, Syapse Team on Clinical Genomics Service for Oncologists

NEW YORK (GenomeWeb) – Syapse and Intermountain Healthcare said today that they will collaborate to offer Intermountain's network of oncologists, tools for genomics-driven cancer care.

Intermountain is a non-profit system of 22 hospitals, 185 physician clinics, and an affiliated health insurance company. It selected Syape's software to provide oncologists with access to tumor genome profiling, data analysis, and drug procurement services.

Syapse's software — a resource that integrates data from multiple sources to provide a clearer view of patients' clinical and genomics data — will underlie the so-called Intermountain Cancer Genomics clinical service, which will offer cost-effective, genomics-based, personalized treatment planning, the firms said. Oncologists will use the web-based system to order molecular tests, view genomic results and tumor board interpretations, select treatments, and order drugs targeted to a patient's specific genomic makeup.

"Software is critical for helping oncologists harness the power of complex genomics and clinical data," Lincoln Nadauld, director of cancer genomics at Intermountain Healthcare, said in a statement.

The service leverages Intermountain’s in-house infrastructure, which includes a clinical sequencing laboratory and an affiliated health insurance plan. Clients will also benefit from the expertise of a molecular tumor board in choosing effective treatment options, the firms said.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.